Amyris traded at $1.68 this Thursday May 12th, increasing $0.08 or 4.69 percent since the previous trading session. Looking back, over the last four weeks, Amyris gained 62.36 percent. Over the last 12 months, its price fell by 84.77 percent. Looking ahead, we forecast Amyris to be priced at 3.16 by the end of this quarter and at 2.94 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Advanced Emissions 5.07 -0.07 -1.36% -3.43%
Albemarle 212.70 -0.33 -0.16% 34.88%
Amyris 1.68 0.08 4.69% -84.77%
BASF 48.67 -0.39 -0.79% -29.37%
Braskem 40.28 -0.54 -1.32% -21.21%
Capstone Green Energy Corp 2.37 -0.07 -2.67% -66.69%
Croda International 6,814.96 58.96 0.87% 4.30%
Chevron 164.63 1.47 0.90% 54.32%
DSM 141.95 1.95 1.39% -4.06%
Enphase Energy 144.82 7.27 5.29% 26.36%
FutureFuel 6.88 -0.03 -0.43% -53.32%
Flotek Industries 1.12 -0.02 -1.33% -41.32%
Givaudan 3,586.00 6.00 0.17% -6.30%
HollyFrontier 44.44 -0.60 -1.33% 28.85%
Ion Geophysical 0.37 0.02 5.76% -79.48%
Marathon Petroleum 92.60 0.64 0.70% 57.54%
Plug Power 13.69 0.24 1.78% -38.44%
Solvay 92.22 0.62 0.68% -18.89%
Exxon Mobil 86.22 -0.57 -0.66% 45.40%

Indexes Price Day Year
USND 11371 6.73 0.06% -13.36%
US2000 1739 21.24 1.24% -19.88%

Amyris
Amyris, Inc. is a synthetic biotechnology company. The Company applies its Lab-to-Market biotechnology platform to engineer, manufacture and market high performance, natural and sustainably sourced products using its computational tools, strain construction tools, screening and analytics tools, and advanced lab automation and data integration. The Company's biotechnology platform enables users to rapidly engineer microbes and use them as catalysts to metabolize renewable, plant-sourced sugars into high-value ingredients that it manufactures at industrial scale. Through the combination of its biotechnology platform and industrial fermentation process, the Company has developed, produced, and commercialized many distinct molecules. The Company is focused on three market areas, Health & Wellness, Clean Beauty and Flavor & Fragrance.